Carr K E, Hazzard R A, Reid S, Hodges G M
School of Biomedical Science/Anatomy, Queen's University, Belfast, Northern Ireland.
Pharm Res. 1996 Aug;13(8):1205-9. doi: 10.1023/a:1016064320334.
The present study examines the relationship between size and particle transit across the mucosal barrier of the gastrointestinal tract to other sites of the body. The extent of particle uptake with increasing size, the tissue distribution and cut-off points for 2-20 microns particles is investigated.
An established fluorescent latex particle-young adult rat model is used and particle numbers in small intestine and mesenteric lymph nodes, 0.5 h post administration, counted by fluorescence microscopy in bulk tissue specimens and cryosections.
Bulk tissue analysis provides evidence for the presence of particles of all sizes in the Peyer's patch regions, but only for 2 microns particles in the nodal tissues. Microscopy establishes uptake of both 2 and 6 microns particles in most intestinal and nodal tissue sites and compartments. By contrast, uptake of the larger particles is much reduced.
Although more of the smaller (2 microns) particles are taken up, particularly by epithelial tissues, the 6 microns size appears more efficient in terms of volume translocated to lymph nodes. This could have implications in the therapeutic use of particles for drug and vaccine delivery and for radiation safety.
本研究探讨胃肠道黏膜屏障处颗粒大小与颗粒转运至身体其他部位之间的关系。研究了随着颗粒尺寸增加其摄取程度、组织分布以及2 - 20微米颗粒的截止点。
使用已建立的荧光乳胶颗粒 - 成年大鼠模型,给药后0.5小时,通过荧光显微镜对大体组织标本和冷冻切片计数小肠和肠系膜淋巴结中的颗粒数量。
大体组织分析表明派尔集合淋巴结区域存在各种尺寸的颗粒,但淋巴结组织中仅存在2微米的颗粒。显微镜检查证实大多数肠道和淋巴结组织部位及隔室均摄取了2微米和6微米的颗粒。相比之下,较大颗粒的摄取量大幅减少。
虽然更多较小(2微米)的颗粒被摄取,尤其是被上皮组织摄取,但就转运至淋巴结的体积而言,6微米尺寸的颗粒似乎更有效。这可能对颗粒在药物和疫苗递送以及辐射安全治疗应用方面有影响。